These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 36205914)

  • 1. Proteinopathies: Deciphering Physiology and Mechanisms to Develop Effective Therapies for Neurodegenerative Diseases.
    Chopra G; Shabir S; Yousuf S; Kauts S; Bhat SA; Mir AH; Singh MP
    Mol Neurobiol; 2022 Dec; 59(12):7513-7540. PubMed ID: 36205914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases.
    Soto C; Pritzkow S
    Nat Neurosci; 2018 Oct; 21(10):1332-1340. PubMed ID: 30250260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expedition into Taurine Biology: Structural Insights and Therapeutic Perspective of Taurine in Neurodegenerative Diseases.
    Bhat MA; Ahmad K; Khan MSA; Bhat MA; Almatroudi A; Rahman S; Jan AT
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32516961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein misfolding and neurodegeneration.
    Soto C; Estrada LD
    Arch Neurol; 2008 Feb; 65(2):184-9. PubMed ID: 18268186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic prions and other human neurodegenerative proteinopathies.
    Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
    Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequestration of cellular interacting partners by protein aggregates: implication in a loss-of-function pathology.
    Yang H; Hu HY
    FEBS J; 2016 Oct; 283(20):3705-3717. PubMed ID: 27016044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting small heat shock proteins to degrade aggregates as a potential strategy in neurodegenerative diseases.
    Lei T; Xiao Z; Bi W; Cai S; Yang Y; Du H
    Ageing Res Rev; 2022 Dec; 82():101769. PubMed ID: 36283618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
    Victoria GS; Zurzolo C
    J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-free amplification of prions: Where do we stand?
    Cazzaniga FA; De Luca CMG; Bistaffa E; Consonni A; Legname G; Giaccone G; Moda F
    Prog Mol Biol Transl Sci; 2020; 175():325-358. PubMed ID: 32958239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using reporters of different misfolded proteins reveals differential strategies in processing protein aggregates.
    Schneider KL; Ahmadpour D; Keuenhof KS; Eisele-Bürger AM; Berglund LL; Eisele F; Babazadeh R; Höög JL; Nyström T; Widlund PO
    J Biol Chem; 2022 Nov; 298(11):102476. PubMed ID: 36096201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock proteins as suppressors of accumulation of toxic prefibrillar intermediates and misfolded proteins in neurodegenerative diseases.
    Arawaka S; Machiya Y; Kato T
    Curr Pharm Biotechnol; 2010 Feb; 11(2):158-66. PubMed ID: 20170473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases.
    Yoshida S; Hasegawa T
    Neurochem Int; 2022 May; 155():105307. PubMed ID: 35181393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
    Costanzo M; Zurzolo C
    Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carnosol Reduced Pathogenic Protein Aggregation and Cognitive Impairment in Neurodegenerative Diseases Models via Improving Proteostasis and Ameliorating Mitochondrial Disorders.
    Chen Y; Qin Q; Zhao W; Luo D; Huang Y; Liu G; Kuang Y; Cao Y; Chen Y
    J Agric Food Chem; 2022 Aug; 70(34):10490-10505. PubMed ID: 35973126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mathematical model of the dynamics of prion aggregates with chaperone-mediated fragmentation.
    Davis JK; Sindi SS
    J Math Biol; 2016 May; 72(6):1555-78. PubMed ID: 26297259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lanosterol Suppresses the Aggregation and Cytotoxicity of Misfolded Proteins Linked with Neurodegenerative Diseases.
    Upadhyay A; Amanullah A; Mishra R; Kumar A; Mishra A
    Mol Neurobiol; 2018 Feb; 55(2):1169-1182. PubMed ID: 28102469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock proteins: therapeutic drug targets for chronic neurodegeneration?
    Sajjad MU; Samson B; Wyttenbach A
    Curr Pharm Biotechnol; 2010 Feb; 11(2):198-215. PubMed ID: 20166961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit.
    Guest WC; Silverman JM; Pokrishevsky E; O'Neill MA; Grad LI; Cashman NR
    J Toxicol Environ Health A; 2011; 74(22-24):1433-59. PubMed ID: 22043906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of molecular chaperones in neurodegenerative disorders.
    Meriin AB; Sherman MY
    Int J Hyperthermia; 2005 Aug; 21(5):403-19. PubMed ID: 16048838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.